After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
The chip enables the detection of 30 fungal pathogens of systemic mycoses at species or genus level with a single test. In addition to 6 Aspergillus and 13 Candida group species, Fusarium spp., Mucor spp. and others are also represented on the chip.
Learn more here: zytomed-systems.com, or contact your local sales representative directly to explore your testing options.
Breast cancer is one of the most common cancers in women worldwide. In Germany, every 8th woman is diagnosed with breast cancer. Until now, therapies have been based on the presence/absence of (hormone) receptors or the Her2 receptor in metastatic/non-metastatic breast cancer.